B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation
Open Access
- 15 October 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 108 (8), 2712-2719
- https://doi.org/10.1182/blood-2006-03-014001
Abstract
B cells currently are not viewed as being capable of producing granzyme B or being cytotoxic. We found that B-chronic lymphocytic leukemia (B-CLL) cells treated with interleukin-21 (IL-21) produce low levels of granzyme B. The addition of either CpG oligodeoxynucleotide (ODN) or anti-B-cell-receptor antibody (anti-BCR) to IL-21 results in enhanced production of functional granzyme B by B-CLL cells. B-CLL cells treated with IL-21 and CpG ODN undergo apoptosis and are able to induce apoptosis of untreated bystander B-CLL cells. This effect can be inhibited by anti-granzyme B antibody. Benign human B cells, Epstein-Barr virus (EBV)-transformed lymphoblasts, and many standard lymphoma cell lines produce high levels of granzyme B in response to IL-21 and anti-BCR. Our results suggest that the ability to induce production of functional granzyme B by B cells could open new approaches to the therapy of B-CLL and other B-cell malignancies. Our findings also have significant implications for our understanding of the role of B cells for immune regulation and for a variety of immune phenomena, including cancer immunity, autoimmunity, and infectious immunity.Keywords
This publication has 34 references indexed in Scilit:
- Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiationNature Reviews Immunology, 2005
- Good prognosis cytogenetics in B-cell chronic lymphocytic leukemia is associated in vitro with low susceptibility to apoptosis and enhanced immunogenicityLeukemia, 2005
- B-Cell Lymphomas Differ in their Responsiveness to CpG OligodeoxynucleotidesClinical Cancer Research, 2005
- Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and functionThe Journal of Experimental Medicine, 2005
- IL-21: a novel IL-2–family lymphokine that modulates B, T, and natural killer cell responsesJournal of Allergy and Clinical Immunology, 2003
- Lymphocyte-Mediated CytotoxicityAnnual Review of Immunology, 2002
- Effect of Immunostimulatory CpG-Oligonucleotides in Chronic Lymphocytic Leukemia B CellsLeukemia & Lymphoma, 2001
- Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: Costimulation with IL-2 results in a highly immunogenic phenotypeExperimental Hematology, 2000
- A Cytosolic Granzyme B Inhibitor Related to the Viral Apoptotic Regulator Cytokine Response Modifier A Is Present in Cytotoxic LymphocytesJournal of Biological Chemistry, 1996
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995